Senator Ron Wyden Proposes Legislation To Regulate Hemp Industry and Protect Minors

U.S. Senator Ron Wyden (D-Ore) has introduced the Cannabinoid Safety and Regulation Act (CSRA), designed to establish federal regulations for the hemp industry and prevent hemp-derived products from reaching minors. In the absence of oversight following the 2018 Farm Bill, which legalized hemp, “hemp-derived cannabinoid products have flooded into national markets” with varying levels of safety and quality, according to the bill. Many of these products are “untested, falsely labeled, contain dangerous chemicals, and are marketed to children.” The CSRA aims to address these concerns by setting strict standards for manufacturing, testing, and labeling while establishing a federal age limit of 21 for the purchase of these products.

Key Takeaways from the Cannabinoid Safety and Regulation Act

The proposed legislation introduces several key measures, prioritizing consumer safety and providing a consistent regulatory framework across states. These include:

• Federal Age Limit and Marketing Restrictions: The CSRA sets a federal age limit of 21 for purchasing hemp-derived cannabinoid products. To further protect minors, the bill prohibits the use of flavors, packaging, or labeling that could appeal to children, such as “cartoons, anthropomorphic figures, and candy or snack forms.” This provision aims to deter marketing practices that may attract young consumers.
• Manufacturing and Testing Standards: The bill requires all producers of hemp-derived cannabinoid products, including foods, beverages, topicals, and supplements, to register with the FDA. These products must undergo rigorous testing for contaminants and must meet “manufacturing and testing requirements to ensure safety of all products.” The bill emphasizes that this regulatory framework is essential to prevent unsafe products from reaching consumers.
• Prohibition of Synthetic Cannabinoids: The CSRA explicitly bans synthetic cannabinoids from the market. This measure is intended to eliminate products that have been linked to adverse health effects and pose a higher risk to public health.
• Labeling Requirements: The legislation mandates clear and accurate labeling of all hemp-derived cannabinoid products. Labels must convey the potency and potential risks of consumption, as well as a statement that the product has not been reviewed or approved by the FDA. According to the bill, these provisions aim to provide “truth-in-labeling requirements” that will help consumers make informed choices about the products they purchase.
• State Flexibility in Regulation and Taxation: While the CSRA sets a baseline for federal regulations, it does not prevent states from further regulating or taxing hemp-derived cannabinoid products. The bill acknowledges, “Many states have taken regulatory or legislative action to prohibit or regulate hemp-derived cannabinoid products; this legislation respects states’ rights to do so.” This flexibility is to allow states to address specific local concerns while maintaining a consistent national standard for safety and quality.
• Public Safety and Research Initiatives: The act includes funding for a $125 million underage cannabis use prevention grant program and a $200 million state cannabis-impaired driving prevention program. It also supports research to develop standards for cannabis impairment and a potential “cannabis breathalyzer” to address drugged driving concerns.
• Recall Authority and Import Standards: The FDA will have the authority to recall products if necessary to protect public health. Additionally, all imported cannabinoid products must meet the same standards as those produced domestically.

The Cannabinoid Safety and Regulation Act seeks to establish a comprehensive regulatory structure for hemp-derived products, addressing safety concerns while allowing for state-level adaptations. As the bill moves forward, it will be considered alongside ongoing debates about consumer safety, industry standards, and the appropriate balance between state and federal regulatory roles in the evolving hemp market.